Search Options Stock News and Analysis from Schaeffer's

Dynavax Technologies Stock Soars on Buyout Buzz

https://www.schaeffersresearch.com/content/news/2025/12/24/dynavax-technologies-stock-soars-on-buyout-buzz

12/24/2025 11:55 AM

Biotech stock Dynavax Technologies Corp (NASDAQ:DVAX) is soaring today, last seen up 38.7% at $15.43, after reports that Sanofi (SNY) plans to acquire the company in an all-cash deal worth roughly $2...

Vaccine Stock Explodes After Sanofi Deal

https://www.schaeffersresearch.com/content/news/2024/05/10/vaccine-stock-explodes-after-sanofi-deal

5/10/2024 10:07 AM

Novavax Inc (NASDAQ:NVAX) stock is up 130% to trade at $10.82 today, by far the best stock on the Nasdaq this morning. The drugmaker signed a co-licensing agreement with French pharma giant Sanofi to ...

Sanofi Suspends mRNA Vaccine Development Amid Stiff Competition

https://www.schaeffersresearch.com/content/news/2021/09/28/sanofy-suspends-mrna-vaccine-development-amid-stiff-competition

9/28/2021 10:03 AM

Sanofi SA (NASDAQA:SNY) announced that it will be suspending any further developments of its mRNA-based Covid-19 vaccine, despite positive results in its last study, as inoculations from Moderna (MRN...

Expedited COVID-19 Trials Give REGN a Boost

https://www.schaeffersresearch.com/content/news/2020/07/06/expedited-covid-19-trials-give-regn-a-boost

7/6/2020 9:41 AM

Biotech Regeneron Pharmaceuticals Inc (NASDAQ:REGN) is getting a boost this morning after news that it's starting phase 3 trials for its antibody drug cocktail to treat COVID-19. This trial comes jus...

SNY Stock Pops on First-Quarter Results

https://www.schaeffersresearch.com/content/news/2020/04/24/sny-stock-pops-on-first-quarter-results

4/24/2020 10:06 AM

French pharmaceutical maker Sanofi SA (NASDAQ:SNY) is up 2.2% at $49.45 after releasing its first-quarter results and confirming its 2020 outlook. The company announced a 16.1% rise in income at cons...

PEOPLE ALSO SEARCH FOR

-notable-earning-reports